US Mammography Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
US · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$1.07 BnPlaceholder estimate
Estimate 2025$1.13 Bn44.2% of the global market
Projected 2034$1.97 Bn 73.3%Adds $831.9 Mn over 9 forecast years
CAGR 2025–20346.3%Faster than 48% of 180 Medical Devices markets here
Key players5
US is 44.23% of the global market.
In North America, the largest is US (this report) at $1.13 Bn.
1,703 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 20 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The US Mammography Market Analysis Executive Summary
Mammography systems take low-dose X-ray images of the breast to find cancer early.
Key segments of the mammography market include product (2D Digital Mammography, 3D Tomosynthesis and Contrast-Enhanced Mammography) and setting (Hospitals, Breast Care Centers and Diagnostic Centers).
US Mammography market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
US Mammography Market Dynamics
Market Growth Drivers
More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the mammography market. Clinicians also use imaging earlier in care.
Opportunity
AI-assisted reading, compact systems for clinics and the replacement of old scanners give the mammography market room to grow.
Market Restraints
High equipment prices, a shortage of trained staff and long replacement cycles in public hospitals hold back the mammography market.
Competitive Landscape for Mammography Market in the US
The mammography market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Mammography Market in the US
Mammography in the US: rules, payment and research
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).[2] ClinicalTrials.gov lists 1,703 studies on Mammography that are recruiting, active or about to start in the US.[3]
[3]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 20 Nov 2026.
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how mammography products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in the US.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Mammography in context
The US compared
Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]
[1]World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
Placeholder estimate: about $1.13 Bn in 2025, rising to about $1.97 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Mammography market in the US growing?
Placeholder estimate: about 6.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Mammography market report cover?
The report splits the market by product (2D Digital Mammography, 3D Tomosynthesis, Contrast-Enhanced Mammography) and setting (Hospitals, Breast Care Centers, Diagnostic Centers).
Who are the key players in the Mammography market?
Key players include Hologic, Inc., GE Healthcare, Siemens Healthineers, FUJIFILM Holdings Corporation and Planmed.
What is driving the Mammography market?
More imaging for cancer and heart disease, older populations and sharper, faster scanners are driving the mammography market. Clinicians also use imaging earlier in care.
Who regulates Mammography in the US?
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA). Source: US Food and Drug Administration. Checked 14 Nov 2026.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How many clinical trials on Mammography are running in the US?
1,703 studies are recruiting, active or about to start in the US, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 20 Nov 2026.
How much research is published on Mammography?
PubMed lists 7,524 papers on Mammography added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 20 Nov 2026.